180 related articles for article (PubMed ID: 2043705)
1. Erythropoietin and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels in sera of patients with HIV infection.
Reddy MM; Grieco MH
Int J STD AIDS; 1991; 2(2):128-32. PubMed ID: 2043705
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
Herold M; Meise U; Günther V; Rössler H; Zangerle R
Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
Levine JD; Allan JD; Tessitore JH; Falcone N; Galasso F; Israel RJ; Groopman JE
Blood; 1991 Dec; 78(12):3148-54. PubMed ID: 1742482
[TBL] [Abstract][Full Text] [Related]
4. Neopterin and alpha and beta interleukin-1 levels in sera of patients with human immunodeficiency virus infection.
Reddy MM; Grieco MH
J Clin Microbiol; 1989 Sep; 27(9):1919-23. PubMed ID: 2789233
[TBL] [Abstract][Full Text] [Related]
5. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation.
Agostini C; Trentin L; Zambello R; Bulian P; Caenazzo C; Cipriani A; Cadrobbi P; Garbisa S; Semenzato G
J Immunol; 1992 Nov; 149(10):3379-85. PubMed ID: 1431112
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.
Hewitt RG; Morse GD; Lawrence WD; Maliszewski ML; Santora J; Bartos L; Bonnem E; Poiesz B
Antimicrob Agents Chemother; 1993 Mar; 37(3):512-22. PubMed ID: 8460920
[TBL] [Abstract][Full Text] [Related]
7. The use of GM-CSF in AIDS.
Scadden DT
Infection; 1992; 20 Suppl 2():S103-6. PubMed ID: 1283604
[TBL] [Abstract][Full Text] [Related]
8. GM-CSF production by CD4+ T-lymphocytes is selectively impaired during the course of HIV-1 infection. A possible indication of a preferential lesion of a specific subset of peripheral blood CD4+ T-lymphocytes.
Re MC; Zauli G; Furlini G; Giovannini M; Ranieri S; Ramazzotti E; Vignoli M; La Placa M
Microbiologica; 1992 Jul; 15(3):265-70. PubMed ID: 1354325
[TBL] [Abstract][Full Text] [Related]
9. The use of hematopoietic hormones in HIV infection and AIDS-related malignancies.
Miles SA; Golde DW; Mitsuyasu RT
Hematol Oncol Clin North Am; 1991 Apr; 5(2):267-80. PubMed ID: 2022593
[TBL] [Abstract][Full Text] [Related]
10. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
Hermans P
AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of CD4 antigen in sera of human immunodeficiency virus-infected populations.
Reddy MM; Vodian M; Grieco MH
J Clin Microbiol; 1990 Aug; 28(8):1744-6. PubMed ID: 1975594
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha in patients with human immunodeficiency virus (HIV) type 1 infection.
Hober D; Ajana F; Petit MC; Sartiaux C; Boniface M; Caillaux M; Mouton Y; Wattre P; Maniez-Montreuil M
Microbiol Immunol; 1993; 37(10):785-92. PubMed ID: 7904721
[TBL] [Abstract][Full Text] [Related]
13. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection.
Chironna M; Fanelli M; Potenza D; Serio G; Quarto M
Int J Clin Lab Res; 1994; 24(2):90-3. PubMed ID: 7919434
[TBL] [Abstract][Full Text] [Related]
14. Immune impairments and antibodies to HTLVIII/LAV in asymptomatic male homosexuals in Israel: relevance to the risk of acquired immune deficiency syndrome (AIDS).
Bentwich Z; Saxinger C; Ben-Ishay Z; Burstein R; Berner Y; Pecht M; Trainin N; Levin S; Handzel ZT
J Clin Immunol; 1987 Sep; 7(5):376-80. PubMed ID: 2443528
[TBL] [Abstract][Full Text] [Related]
15. Soluble tumor necrosis factor alpha receptors (sTNF-Rs) in HIV-1-infected intravenous drug users: change in circulating sTNF-R type II level and survival for AIDS patients.
Ajello F; La Licata R; Lodato M; Vitale F; Bonura F; Valenti R; Bruno M; Romano N
Eur J Epidemiol; 2000 Mar; 16(3):209-16. PubMed ID: 10870934
[TBL] [Abstract][Full Text] [Related]
16. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection.
Donahue RE; Johnson MM; Zon LI; Clark SC; Groopman JE
Nature; 1987 Mar 12-18; 326(6109):200-3. PubMed ID: 2434864
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of circulating immune complexes in human immunodeficiency virus infection.
Reddy MM; Grieco MH
J Clin Lab Anal; 1990; 4(2):95-8. PubMed ID: 2313475
[TBL] [Abstract][Full Text] [Related]
18. Management of the hematologic complications of human immunodeficiency virus infection.
Groopman JE
Rev Infect Dis; 1990; 12(5):931-7. PubMed ID: 2237134
[TBL] [Abstract][Full Text] [Related]
19. Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia.
Rarick MU; Loureiro C; Groshen S; Sullivan-Halley J; Gill PS; Bernstein-Singer M; Levine AM
J Acquir Immune Defic Syndr (1988); 1991; 4(6):593-7. PubMed ID: 1673713
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia.
Si Q; Cosenza M; Zhao ML; Goldstein H; Lee SC
Glia; 2002 Aug; 39(2):174-83. PubMed ID: 12112368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
